Erasca, Inc. (ERAS)
NGS · Common · CUSIP 29479A108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ERAS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
29479A108
IPO
7/16/2021 · $16.00/unit
Business: Erasca, Inc. is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Company Contact

CEO
Jonathan E. Lim
CFO
David M. Chacko
Headquarters
3115 Merryfield Row, Suite 300, San Diego, CA 92121
Phone
858-465-6511
Investor Relations
Joyce Allaire, LifeSci Advisors · jallaire@lifesciadvisors.com
General Email
info@erasca.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »